Skip to main content
Log in

Normal mitogen-induced suppression of the interleukin-6 (IL-6) response and its deficiency in systemic lupus erythematosus

  • Original Articles
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

A low-frequency suppressor-cell population in normal peripheral blood inhibits the B-cell CESS response to IL-6, following pokeweed mitogen stimulation. The suppression of IL-6 responsiveness is (i) radiation sensitive, (ii) directed against CESS targets and not mediated by inhibition of IL-6 production, and (iii) associated with nonspecific cytotoxic activity against CESS targets. The generation of these cytolytic cells is also radiation sensitive. A correlation was found between PWM-induced cytotoxicity against CESS and the suppression of IL-6-dependent IgG production. But cytotoxicity toward CESS targets is not responsible for this suppression because (i) IL-2 induces equivalent or greater nonspecific cytotoxicity against CESS in the total absence of suppression of CESS-derived IgG production and (ii) suppression is also induced by mitogen-activated PBL separated from CESS targets by a cell-impermeable membrane. This suppression was not mediated by TNFα/β or IFN-γ. In systemic lupus erythematosus, suppression of IL-6-dependent IgG production is impaired in patients with active disease (29.2±13.7%) compared to patients with inactive disease (70±19.5%) or normal controls (82.8±9.2%). There is also a defect in mitogen-induced nonspecific cytotoxicity in active SLE (specific lysis 15.1±3.5%, compared to 34±4% in normals). Pokeweed mitogen-activated PBL can therefore normally induce suppression of B-cell IL-6 responses and this response is deficient in lupus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Warrington RJ: B cell differentiation factor production in systemic lupus erythematosus. J Rheumatol 15:55–58, 1988

    Google Scholar 

  2. Brieva JA, Targan S, Stevens RH: NK and T cell subsets regulate antibody production by human in vivo antigen-induced lymphoblastoid B cells. J Immunol 132:611–615, 1984

    Google Scholar 

  3. Arai S, Yamamoto H, Itoh K, Kumagi K: Suppressive effect of human natural killer cells on pokeweed mitogen-induced B cell differentiation. J Immunol 131:651–657, 1983

    Google Scholar 

  4. Storkus WJ, Dawson JR: B cell sensitivity to Natural Killing: Correlation with target cell stage & differentiation and state of activation. J Immunol 136:1542–1547, 1986

    Google Scholar 

  5. Fox EJ, Cook RG, Lewis DE, Rich RR: Proliferative signals for human suppressor cells: Helper cells stimulated with pokeweed mitogen in vitro produce a suppressor growth factor. J Clin Invest 78:214–220, 1986

    Google Scholar 

  6. Elmasry MN, Fox EJ, Rich RR: Sequential effects of prostaglandins and interferon-γ on differentiation of CD8+ suppressor cells. J Immunol 139:688–694, 1987

    Google Scholar 

  7. Warrington RJ: Interleukin-2 abnormalities in systemic lupus erythematosus and rheumatoid arthritis. A role for overproduction of IL-2 in human autoimmunity. J Rheumatol 15:616–620, 1989

    Google Scholar 

  8. Boyum A: Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 21 (Suppl 97):77–89, 1983

    Google Scholar 

  9. Wilkins JA, Jordan Y, Rutherford WJ, Warrington RJ: T cell factor-mediated suppression of immunoglobulin secretion by a human B lymphoblastoid cell line. J Immunol 131:298–302, 1983

    Google Scholar 

  10. Wilkins JA, Warrington RJ: The production of immunoregulatory factors by a human macrophage-like cell line. III. The relationship of IDS-U937 to human interferons. Cell Immunol 86:354–361, 1984

    Google Scholar 

  11. Bolhuis RL, Schuit HRE, Nooyen AM, Rontelup, CPM: Characterization of Natural Killer (NK) cells and Killer (K) cells in human blood: Discrimination between NK and K cell activities. Eur J Immunol 8:731–740, 1978

    Google Scholar 

  12. Honda M, Cahn C, Shevach EM: Characterization and partial purification of a specific interleukin 2 inhibitor. J Immunol 135:1834–1839, 1985

    Google Scholar 

  13. Tiku K, Tiku ML, Liu S, Skosey JL: Normal human neutrophils are a source of a specific interleukin 1 inhibitor. J Immunol 136:3686–3692, 1986

    Google Scholar 

  14. Rayner AA, Grimm EA, Lotze HT, Wilson DT, Rosenberg JA: Lymphokine activated killer (LAK) cell phenomenon. IV. Lysis by LAK cell clones of fresh tumor cells from autologous and multiple allogeneic tumors. J Natl Cancer Inst 75:67–75, 1985

    Google Scholar 

  15. Bonavida B, Robins A, Saxon A: Lectin-dependent cellular cytotoxicity in man. Transplantation 23:261–270, 1977

    Google Scholar 

  16. Murakawa Y, Takada S, Ueda Y, Suzuki N, Hoshino T, Sakane T: Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus. J Immunol 134:187–195, 1985

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Warrington, R.J., Rutherford, W.J. Normal mitogen-induced suppression of the interleukin-6 (IL-6) response and its deficiency in systemic lupus erythematosus. J Clin Immunol 10, 52–60 (1990). https://doi.org/10.1007/BF00917498

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00917498

Key words

Navigation